We are live on ! Find out more
QTTB icon

Q32 Bio

54 hedge funds and large institutions have $60.6M invested in Q32 Bio in 2026 Q1 according to their latest regulatory filings, with 12 funds opening new positions, 14 increasing their positions, 9 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

127% more capital invested

Capital invested by funds: $26.7M → $60.6M (+$34M)

56% more repeat investments, than reductions

Existing positions increased: 14 | Existing positions reduced: 9

50% more first-time investments, than exits

New positions opened: 12 | Existing positions closed: 8

4% more funds holding

Funds holding: 5254 (+2)

0% more funds holding in top 10

Funds holding in top 10: 44 (0)

0.92% less ownership

Funds ownership: 65.37%64.46% (-0.92%)

Holders
54
Holders Change
+2
Holders Change %
+3.85%
% of All Funds
0.66%
Holding in Top 10
4
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
0.05%
New
12
Increased
14
Reduced
9
Closed
8
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
HI
51
Harbour Investments
Wisconsin
$71
AF
52
Advisornet Financial
Minnesota
$13
DB
53
Danske Bank
Denmark
$6
Millennium Management
54
Millennium Management
New York
-$170K -51,268 Closed
MAM
55
Monaco Asset Management
Monaco
-$169K -50,919 Closed
HF
56
HRT Financial
New York
-$81K -24,698 Closed
XT
57
XTX Topco
Cayman Islands
-$67.6K -20,353 Closed
SRL
58
Scientech Research LLC
New Jersey
-$51.5K -15,510 Closed
Bank of America
59
Bank of America
North Carolina
-$3.44K -1,035 Closed
JP Morgan Chase
60
JP Morgan Chase
New York
-$1.08K -324 Closed
Barclays
61
Barclays
United Kingdom
-$63 -19 Closed
KFP
62
Kerr Financial Planning
California
+$2.85K +600 New

QTTB Hedge Fund Activity: Q1 2026 in Review

54 of the 8,150 institutional investors tracked by Wall St. Rank reported a position in Q32 Bio (QTTB) for Q1 2026, worth a combined $60.6M — up 127% from $26.7M a quarter earlier.

Buyers outnumbered sellers: 12 funds opened new QTTB positions and 8 closed out — a net gain of 4 holders — while 14 added to existing stakes and 9 trimmed.

The largest buyer was Opaleye Management, adding an estimated $4.95M. The largest seller was Acorn Capital Advisors, cutting an estimated $847K.

  • 54 institutional investors held Q32 Bio (QTTB) as of Q1 2026, up from 52 in Q4 2025.
  • Funds reported $60.6M of Q32 Bio stock for Q1 2026, up 127% quarter-over-quarter.
  • 12 funds opened new Q32 Bio positions in Q1 2026 and 8 closed out, a net change of +4 holders.
  • The largest Q32 Bio buyer in Q1 2026 was Opaleye Management, an estimated $4.95M added.
  • The largest Q32 Bio seller in Q1 2026 was Acorn Capital Advisors, an estimated $847K sold.

Based on aggregated 13F filings for Q1 2026.